Brainstorm Cell Therapeutics Stock Market Value
| BCLI Stock | USD 1.58 0.04 2.60% |
| Symbol | Brainstorm |
Brainstorm Cell Ther Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Brainstorm Cell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Brainstorm Cell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Brainstorm Cell.
| 12/01/2024 |
| 03/01/2025 |
If you would invest 0.00 in Brainstorm Cell on December 1, 2024 and sell it all today you would earn a total of 0.00 from holding Brainstorm Cell Therapeutics or generate 0.0% return on investment in Brainstorm Cell over 90 days. Brainstorm Cell is related to or competes with Protalix Biotherapeutics, Corvus Pharmaceuticals, Aldeyra, Checkpoint Therapeutics, Werewolf Therapeutics, Edgewise Therapeutics, and Celcuity LLC. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologo... More
Brainstorm Cell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Brainstorm Cell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Brainstorm Cell Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.01 | |||
| Information Ratio | 0.0837 | |||
| Maximum Drawdown | 34.91 | |||
| Value At Risk | (7.39) | |||
| Potential Upside | 14.08 |
Brainstorm Cell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Brainstorm Cell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Brainstorm Cell's standard deviation. In reality, there are many statistical measures that can use Brainstorm Cell historical prices to predict the future Brainstorm Cell's volatility.| Risk Adjusted Performance | 0.0692 | |||
| Jensen Alpha | 0.5676 | |||
| Total Risk Alpha | 0.7639 | |||
| Sortino Ratio | 0.1143 | |||
| Treynor Ratio | 0.7289 |
Brainstorm Cell Ther Backtested Returns
Brainstorm Cell is relatively risky at the moment. Brainstorm Cell Ther secures Sharpe Ratio (or Efficiency) of 0.011, which signifies that the company had a 0.011 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Brainstorm Cell Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Brainstorm Cell's risk adjusted performance of 0.0692, and Mean Deviation of 4.79 to double-check if the risk estimate we provide is consistent with the expected return of 0.0732%. The firm shows a Beta (market volatility) of 0.75, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Brainstorm Cell's returns are expected to increase less than the market. However, during the bear market, the loss of holding Brainstorm Cell is expected to be smaller as well. Brainstorm Cell Ther right now shows a risk of 6.67%. Please confirm Brainstorm Cell Ther value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to decide if Brainstorm Cell Ther will be following its price patterns.
Auto-correlation | -0.71 |
Almost perfect reverse predictability
Brainstorm Cell Therapeutics has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Brainstorm Cell time series from 1st of December 2024 to 15th of January 2025 and 15th of January 2025 to 1st of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Brainstorm Cell Ther price movement. The serial correlation of -0.71 indicates that around 71.0% of current Brainstorm Cell price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.71 | |
| Spearman Rank Test | -0.62 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Brainstorm Cell Ther lagged returns against current returns
Autocorrelation, which is Brainstorm Cell stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Brainstorm Cell's stock expected returns. We can calculate the autocorrelation of Brainstorm Cell returns to help us make a trade decision. For example, suppose you find that Brainstorm Cell has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Brainstorm Cell regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Brainstorm Cell stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Brainstorm Cell stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Brainstorm Cell stock over time.
Current vs Lagged Prices |
| Timeline |
Brainstorm Cell Lagged Returns
When evaluating Brainstorm Cell's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Brainstorm Cell stock have on its future price. Brainstorm Cell autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Brainstorm Cell autocorrelation shows the relationship between Brainstorm Cell stock current value and its past values and can show if there is a momentum factor associated with investing in Brainstorm Cell Therapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:Check out Brainstorm Cell Correlation, Brainstorm Cell Volatility and Brainstorm Cell Alpha and Beta module to complement your research on Brainstorm Cell. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Brainstorm Cell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.